It was reported that an unspecified number of bd saf-t-intima¿ safety system with removable prn 22 ga 0.
75 in (non-dehp) were involved with patients experiencing infection.
Medical intervention was administered as a result.
The following information was provided by the initial reporter: between august 2019 and now, 13 patients have been registered at the geriatrics unit in several different units for having presented inflammations (some of which were significant) at the puncture site of the subcutaneous device, sometimes associated with a local infectious problem, despite compliance with the institutional hygiene protocol in force (use of an alcoholic antiseptic on the skin before setting up the infusion, changing the device after a maximum of 96 hours) by personnel experienced in this type of procedure.
For the other cases mentioned, as these were retrospectively reported cases, the batches were not listed at the time of the adverse event.
Concerning the consequences on patients : 1 patient with hyperthermia due to infection at the subcutaneous infusion site (right thigh) with formation of a collection that required a blade incision and wicking.
1 patient who presented a collection of poor evolution at the sc puncture site on the abdomen: incision of the abscess that shows necrosis + antibiotic therapy + wicking.
1 patient with an abscess on the abdominal wall opposite the cs: antibiotic therapy + incision and drainage of the abscess + wicking.
1 patient with erythematous erythematous inflammatory oozing cupboard on the left flank: removal of the abscess roof for complete evacuation of the collection + antibiotic therapy + wicking.
|